Clinical Trial Update: S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the S-1/leucovorin one week on/one week off regimen for advanced hepatocellular carcinoma; the document does not report results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Second Military Medical University | Conditions: Carcinoma, Liver Diseases | Phase 2 | Status: UNKNOWN